Literature DB >> 15880278

Indication of hepatectomy for cirrhotic patients with hepatocellular carcinoma classified as Child-Pugh class B.

Hideki Nakahara1, Toshiyuki Itamoto, Koji Katayama, Hideki Ohdan, Hiroshi Hino, Makoto Ochi, Hirotaka Tashiro, Toshimasa Asahara.   

Abstract

We clarified the indication of partial hepatectomy in hepatocellular carcinoma (HCC) patients with liver cirrhosis classified as Child-Pugh class B. Univariate analysis revealed that adverse prognostic factors were (1) the presence of ascites, (2) elevated total bilirubin (1.5 mg/dl or higher), (3) reduced choline esterase (160 IU/ or lower), (4) elevated alpha-fetoprotein (AFP) (400 ng/ml or higher), (5) microscopic vascular invasion, and (6) non-curative hepatectomy. Microvascular invasion was excluded in the multivariate analysis because this factor could not be predicted before hepatectomy. Multivariate analysis revealed that independent adverse prognostic factors were (1) elevated total bilirubin (1.5 mg/dl or higher), (2) presence of ascites, (3) elevated AFP (400 ng/ml or higher), and (4) non-curative hepatectomy. The overall 5-year survival rate of patients with none of or only one of the four adverse prognostic factors was 45.8%. The overall 5-year survival rate of patients with two or more adverse prognostic factors was only 7.0%. Partial hepatectomy is the first choice of treatment for patients with none of or only one of the four adverse prognostic factors, whereas orthotopic liver transplantation or other conservative treatment should be considered for patients with two or more adverse prognostic factors.

Entities:  

Mesh:

Year:  2005        PMID: 15880278     DOI: 10.1007/s00268-005-7750-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  21 in total

Review 1.  Prognostic prediction and treatment strategy in hepatocellular carcinoma.

Authors:  Jordi Bruix; Josep M Llovet
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

2.  Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Authors:  S Arii; Y Yamaoka; S Futagawa; K Inoue; K Kobayashi; M Kojiro; M Makuuchi; Y Nakamura; K Okita; R Yamada
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

3.  [Liver lobes and segments: notes on the anatomical architecture and surgery of the liver ].

Authors:  C COUINAUD
Journal:  Presse Med       Date:  1954-05-05       Impact factor: 1.228

4.  Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.

Authors:  Shinichi Ueno; Gen Tanabe; Kenshuke Nuruki; Makoto Oketani; Yasuji Komorizono; Hirohumi Hokotate; Yoshihiko Fukukura; Yoshirou Baba; Yasuhiro Imamura; Takashi Aikou
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

5.  Resection of hepatocellular carcinoma in patients with cirrhosis.

Authors:  J Balsells; R Charco; J L Lazaro; E Murio; V Vargas; E Allende; C Margarit
Journal:  Br J Surg       Date:  1996-06       Impact factor: 6.939

6.  Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis.

Authors:  P E Majno; F P Sarasin; G Mentha; A Hadengue
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

7.  Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Authors:  J M Llovet; J Fuster; J Bruix
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

8.  Surgical treatment of hepatocellular carcinoma on cirrhosis: a Western experience.

Authors:  A Mazziotti; G L Grazi; A Cavallari
Journal:  Hepatogastroenterology       Date:  1998-08

9.  Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma.

Authors:  Y Sasaki; S Imaoka; S Masutani; I Ohashi; O Ishikawa; H Koyama; T Iwanaga
Journal:  Surgery       Date:  1992-09       Impact factor: 3.982

10.  Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma.

Authors:  J N Vauthey; D Klimstra; D Franceschi; Y Tao; J Fortner; L Blumgart; M Brennan
Journal:  Am J Surg       Date:  1995-01       Impact factor: 2.565

View more
  7 in total

1.  Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more.

Authors:  Koichi Oishi; Toshiyuki Itamoto; Tsuyoshi Kobayashi; Akihiko Oshita; Hironobu Amano; Hideki Ohdan; Hirotaka Tashiro; Toshimasa Asahara
Journal:  J Gastrointest Surg       Date:  2008-12-03       Impact factor: 3.452

2.  Significance of platelet count in the outcomes of hepatectomized patients with hepatocellular carcinoma exceeding the Milan criteria.

Authors:  Hironobu Amano; Hirotaka Tashiro; Akihiko Oshita; Tsuyoshi Kobayashi; Yoshisato Tanimoto; Shintaro Kuroda; Hirofumi Tazawa; Toshiyuki Itamoto; Toshimasa Asahara; Hideki Ohdan
Journal:  J Gastrointest Surg       Date:  2011-04-22       Impact factor: 3.452

3.  Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy.

Authors:  Saburo Fukuda; Toshiyuki Itamoto; Hironobu Amano; Toshihiko Kohashi; Hideki Ohdan; Hirotaka Tashiro; Toshimasa Asahara
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

4.  Selection criteria for hepatectomy in patients with hepatocellular carcinoma classified as Child-Pugh class B.

Authors:  Shintaro Kuroda; Hirotaka Tashiro; Tsuyoshi Kobayashi; Akihiko Oshita; Hironobu Amano; Hideki Ohdan
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

5.  Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma.

Authors:  Kai-Zhong Luo; Toshiyuki Itamoto; Hironobu Amano; Akihiko Oshita; Yuichiro Ushitora; Yoshisato Tanimoto; Hideki Ohdan; Hirotaka Tashiro; Toshimasa Asahara
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

6.  Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score.

Authors:  Atsushi Nanashima; Junichi Masuda; Satoshi Miuma; Yorihisa Sumida; Takashi Nonaka; Kenji Tanaka; Shigekazu Hidaka; Terumitsu Sawai; Takeshi Nagayasu
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

Review 7.  Assessment of Preoperative Liver Function for Surgical Decision Making in Patients with Hepatocellular Carcinoma.

Authors:  Takashi Kokudo; Kiyoshi Hasegawa; Chikara Shirata; Meguri Tanimoto; Takeaki Ishizawa; Junichi Kaneko; Nobuhisa Akamatsu; Junichi Arita; Nicolas Demartines; Emilie Uldry; Norihiro Kokudo; Nermin Halkic
Journal:  Liver Cancer       Date:  2019-07-26       Impact factor: 11.740

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.